Results 171 to 180 of about 5,269,973 (298)
The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad +2 more
wiley +1 more source
Multiparameter ranking of carbazoles for anti-trypanosome lead discovery. [PDF]
Sharma A +4 more
europepmc +1 more source
Current perspectives in fragment-based lead discovery (FBLD). [PDF]
Lamoree B, Hubbard RE.
europepmc +1 more source
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani +9 more
wiley +1 more source
Systematic computational strategies for identifying protein targets and lead discovery. [PDF]
Kataria A +5 more
europepmc +1 more source
Process of Fragment-Based Lead Discovery-A Perspective from NMR. [PDF]
Ma R, Wang P, Wu J, Ruan K.
europepmc +1 more source
Loss of eIF5A rewires thapsigargin‐mediated endoplasmic reticulum stress responses in multiple myeloma cells by selective translation of mRNA transcripts, consequently dampening thapsigargin‐induced unfolded protein response (UPR) activation and shifting the balance from induction of apoptosis toward cell survival and proliferation.
Demi Both +7 more
wiley +1 more source
Biophysics-Guided Lead Discovery of HBV Capsid Assembly Modifiers. [PDF]
Fan Z +10 more
europepmc +1 more source
Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors. [PDF]
Hanski L, Vuorela P.
europepmc +1 more source
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source

